{"id":456270,"date":"2021-03-11T15:25:09","date_gmt":"2021-03-11T20:25:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456270"},"modified":"2021-03-11T15:25:09","modified_gmt":"2021-03-11T20:25:09","slug":"wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/","title":{"rendered":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc."},"content":{"rendered":"<h2>\nDid You Sell Your Organigram Holdings, Inc. Shares on Wednesday, March 10th? Are You Upset That the Stock Went Up Over 33 Percent Right After You Sold?<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, March  11, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sM9abzHV_11RN6ZHrdbXYOjrjtJ8ZGAXjltfeGiiyg1C13_cj3ZPWJezOrJjPMDLwMmD_6Hud4lmfkNcnkbJJAoibGLasWljHCCc_0u2C8bCrGnC4FYouw7c4Ax-euxF\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a> is investigating potential securities fraud claims on behalf of shareholders <strong>who sold<\/strong> their Organigram Holdings, Inc. (NASDAQ: OGI) shares on Wednesday, March 10, 2021 after hearing the news that BMO Capital Markets analyst, Tamy Chen, cut her recommendation on Organigram Holdings, Inc. to underperform from market perform. The new price target on Organigram Holdings was cut to $2.00 CDN ($1.59 US) per share.<\/p>\n<p align=\"justify\">On this news, the shares closed at $2.89 US per share.<\/p>\n<p>\n        <strong>If you sold U.S. exchange listed shares of Organigram Holdings, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_FmmQaXaYWpWO2A1gTvhGDgK5vpEpkMoYNS_RP5gLgBOEB--hlQCSsL5CdxhX7CgDWY2LvbAkyQjZV6-gfMgIg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <strong>gstone@whafh.com<\/strong><br \/>\n        <\/a>.<\/p>\n<p align=\"justify\">The following day, Thursday, March 11<sup>th<\/sup>, British American Tobacco Plc announced it would acquire a stake of almost 20% in Organigram Holdings, Inc., its biggest expansion into cannabis market. The companies will collaborate on product development and<br \/>focus on next-generation cannabis products, they said in joint statements Thursday. The financial adviser to Organigram Holdings is none other than BMO Capital Markets, the same firm which downgraded the price target just one day earlier.<\/p>\n<p>On this news, shares of Organigram Holdings have traded as high as $3.99 US intraday.<\/p>\n<p align=\"justify\">Wolf Haldenstein Adler Freeman &amp; Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.<\/p>\n<p align=\"justify\">If you wish to discuss this investigation or have any questions regarding your rights and interests in this matter, please immediately contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sM9abzHV_11RN6ZHrdbXYN6E61sHpEjA8DwxAmH3C2cyZej2AU5GThC_vzgw7ejUivGd_IMB1bmYRs8-zZVz_A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Wolf Haldenstein<\/a> by telephone at (800) 575-0735, via e-mail at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DVoroq2u3FSgTi0hyngT8wP3HSkpQB7szexO6jLmHXGpELZWQ3FwWmwmpfP4syz5qCXDvyfjxfXsaLXHb7eont0067XN3C-fg5dTjOlHMug=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">classmember@whafh.com<\/a>, or visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WxI98qp0EKRsaIBx2JC_U8OcAaNGn8KikqUdgghRPoa16yUmYNacqYb5khqELcVjRO6DmOTb2RVOvNhAqD8hZ3Lt2ZVUcn0d3JEDRWKxHEU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.whafh.com. <\/a><\/p>\n<p align=\"justify\">Contact:<\/p>\n<p align=\"justify\">Wolf Haldenstein Adler Freeman &amp; Herz LLP <br \/>Gregory Stone, Director of Case and Financial Analysis<br \/>Kevin Cooper, Esq.<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_FmmQaXaYWpWO2A1gTvhGOrLY53ljUqb0kucDO-xnf9b4Eym0P0vyYVBXEjBH5LrNIG34oJMC4BefUD-uPCIQw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">gstone@whafh.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DVoroq2u3FSgTi0hyngT8wP3HSkpQB7szexO6jLmHXFtDwSpQbAfiY72ZRfmvo7Niv_1JCml12ZGB-vlcxGPWmy1jZXZrtpMnwqygY05_Mo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">classmember@whafh.com<\/a><br \/>Tel: (800) 575-0735 or (212) 545-4774<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee or predict a similar outcome.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8b71b8b2-6d55-4cf6-b2ba-d9dc74cb73c1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Did You Sell Your Organigram Holdings, Inc. Shares on Wednesday, March 10th? Are You Upset That the Stock Went Up Over 33 Percent Right After You Sold? NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating potential securities fraud claims on behalf of shareholders who sold their Organigram Holdings, Inc. (NASDAQ: OGI) shares on Wednesday, March 10, 2021 after hearing the news that BMO Capital Markets analyst, Tamy Chen, cut her recommendation on Organigram Holdings, Inc. to underperform from market perform. The new price target on Organigram Holdings was cut to $2.00 CDN ($1.59 US) per share. On this news, the shares closed at $2.89 US per share. If you sold U.S. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456270","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Did You Sell Your Organigram Holdings, Inc. Shares on Wednesday, March 10th? Are You Upset That the Stock Went Up Over 33 Percent Right After You Sold? NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating potential securities fraud claims on behalf of shareholders who sold their Organigram Holdings, Inc. (NASDAQ: OGI) shares on Wednesday, March 10, 2021 after hearing the news that BMO Capital Markets analyst, Tamy Chen, cut her recommendation on Organigram Holdings, Inc. to underperform from market perform. The new price target on Organigram Holdings was cut to $2.00 CDN ($1.59 US) per share. On this news, the shares closed at $2.89 US per share. If you sold U.S. &hellip; Continue reading &quot;Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T20:25:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.\",\"datePublished\":\"2021-03-11T20:25:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/\",\"name\":\"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\",\"datePublished\":\"2021-03-11T20:25:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/","og_locale":"en_US","og_type":"article","og_title":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk","og_description":"Did You Sell Your Organigram Holdings, Inc. Shares on Wednesday, March 10th? Are You Upset That the Stock Went Up Over 33 Percent Right After You Sold? NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating potential securities fraud claims on behalf of shareholders who sold their Organigram Holdings, Inc. (NASDAQ: OGI) shares on Wednesday, March 10, 2021 after hearing the news that BMO Capital Markets analyst, Tamy Chen, cut her recommendation on Organigram Holdings, Inc. to underperform from market perform. The new price target on Organigram Holdings was cut to $2.00 CDN ($1.59 US) per share. On this news, the shares closed at $2.89 US per share. If you sold U.S. &hellip; Continue reading \"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T20:25:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc.","datePublished":"2021-03-11T20:25:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/"},"wordCount":396,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/","name":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=","datePublished":"2021-03-11T20:25:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODc3NiM0MDYwNTYzIzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolf-haldenstein-adler-freeman-herz-llp-is-investigating-organigram-holdings-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Wolf Haldenstein Adler Freeman &amp; Herz LLP Is Investigating Organigram Holdings, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456270"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456270\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}